Drug discovery platform Exscientia sets terms for $275 million US IPO

Robert Marcus
Sep 27, 2021

Related news

Mar 15
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovation at the intersection of design and technology

Dec 14
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Duke U, Mayo Clinic, et al collab for innovative AI

Sep 15
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Federated learning for predicting clinical outcomes in patients with COVID-19

Nov 11
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AI startups notched another big quarter in a record-breaking year for global funding, mega-rounds, unicorns, exits, and more.

Sep 14
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

How AI simplifies data management for drug discovery

Oct 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The 2021 machine learning, AI, and data landscape

Nov 23
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AI Software Market Set to Reach New Heights Next Year

Sep 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Prospection Secures $45 million to Accelerate Growth of its Powerful Healthcare Insights Technology

Nov 11
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AI startups notched another big quarter in a record-breaking year for global funding, mega-rounds, unicorns, exits, and more.

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus